Stock analysts at StockNews.com began coverage on shares of Mannatech (NASDAQ:MTEX – Get Free Report) in a research note issued to investors on Friday. The firm set a “buy” rating on the stock.
Mannatech Price Performance
Shares of NASDAQ:MTEX opened at $6.75 on Friday. The business’s fifty day moving average price is $7.59 and its two-hundred day moving average price is $8.29. The stock has a market cap of $12.72 million, a PE ratio of -7.58 and a beta of 1.17. The company has a debt-to-equity ratio of 0.09, a quick ratio of 0.56 and a current ratio of 1.08. Mannatech has a one year low of $6.75 and a one year high of $15.10.
Mannatech (NASDAQ:MTEX – Get Free Report) last announced its earnings results on Tuesday, May 14th. The company reported $0.63 EPS for the quarter. The firm had revenue of $29.39 million for the quarter. Mannatech had a negative return on equity of 15.37% and a negative net margin of 1.31%.
About Mannatech
Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.
Read More
- Five stocks we like better than Mannatech
- Where to Find Earnings Call Transcripts
- Celebrate July 4th with These Red, White, & Blue Chip Stocks
- What is the Dogs of the Dow Strategy? Overview and Examples
- AbbVie Stock: A Perfect Dip for Investors to Buy
- Best Aerospace Stocks Investing
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
